Ohkubo K, Suzuki K, Otorii T
Nihon Yakurigaku Zasshi. 1984 Oct;84(4):327-35.
The effects of intracerebroventricularly (i.c.v.) administered prostaglandins (PG) E2, F2a, I2 and their precursor, arachidonic acid (AA), on systemic blood pressure were investigated in anaesthetized rabbits. PGE2 (0.03-1 microgram/0.1 ml/rabbit) elevated blood pressure in a dose-related manner. PGF2a exerted no significant changes on blood pressure. PGI2 (0.3-10 micrograms/0.1 ml/rabbit) lowered blood pressure in a dose-related manner. AA (0.1-10 microgram/0.1 ml/rabbit) dose-independently elevated blood pressure. I.c.v. pretreatment with indomethacin, an inhibitor of cyclooxygenase, abolished the hypertensive effect of AA, but did not influence the hypertensive and hypotensive effect caused by PGE2 and PGI2, respectively. These results suggest that the hypertensive effect of AA may be composed of various actions of the above-mentioned PG and the related substances synthetized from AA in the brain tissues.
在麻醉兔中研究了脑室内(i.c.v.)注射前列腺素(PG)E2、F2α、I2及其前体花生四烯酸(AA)对全身血压的影响。PGE2(0.03 - 1微克/0.1毫升/兔)以剂量相关的方式升高血压。PGF2α对血压无显著影响。PGI2(0.3 - 10微克/0.1毫升/兔)以剂量相关的方式降低血压。AA(0.1 - 10微克/0.1毫升/兔)剂量依赖性地升高血压。用环氧化酶抑制剂吲哚美辛进行脑室内预处理可消除AA的升压作用,但不影响PGE2和PGI2分别引起的升压和降压作用。这些结果表明,AA的升压作用可能由上述PG以及脑组织中由AA合成的相关物质的多种作用组成。